Literature DB >> 25516667

Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification.

Othman R Alharbi1, Nahla A Azzam1, Ahmed S Almalki1, Majid A Almadi1, Khalid A Alswat1, Nazia Sadaf1, Abdulrahman M Aljebreen1.   

Abstract

AIM: To determine the clinical, epidemiological and phenotypic characteristics of ulcerative colitis (UC) in Saudi Arabia by studying the largest cohort of Arab UC patients.
METHODS: Data from UC patients attending gastroenterology clinics in four tertiary care centers in three cities between September 2009 and September 2013 were entered into a validated web-based registry, inflammatory bowel disease information system (IBDIS). The IBDIS database covers numerous aspects of inflammatory bowel disease. Patient characteristics, disease phenotype and behavior, age at diagnosis, course of the disease, and extraintestinal manifestations were recorded.
RESULTS: Among 394 UC patients, males comprised 51.0% and females 49.0%. According to the Montréal classification of age, the major chunk of our patients belonged to the A2 category for age of diagnosis at 17-40 years (68.4%), while 24.2% belonged to the A3 category for age of diagnosis at > 40 years. According to the same classification, a majority of patients had extensive UC (42.7%), 35.3% had left-sided colitis and 29.2% had only proctitis. Moreover, 51.3% were in remission, 16.6% had mild UC, 23.4% had moderate UC and 8.6% had severe UC. Frequent relapse occurred in 17.4% patients, infrequent relapse in 77% and 4.8% had chronic disease. A majority (85.2%) of patients was steroid responsive. With regard to extraintestinal manifestations, arthritis was present in 16.4%, osteopenia in 31.4%, osteoporosis in 17.1% and cutaneous involvement in 7.0%.
CONCLUSION: The majority of UC cases were young people (17-40 years), with a male preponderance. While the disease course was found to be similar to that reported in Western countries, more similarities were found with Asian countries with regards to the extent of the disease and response to steroid therapy.

Entities:  

Keywords:  Epidemiology; Inflammatory bowel disease information system; Saudi Arabia; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 25516667      PMCID: PMC4265614          DOI: 10.3748/wjg.v20.i46.17525

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  47 in total

1.  Clinical epidemiology of Crohn's disease in Arabs based on the Montreal Classification.

Authors:  Iqbal Siddique; Waleed Alazmi; Jaber Al-Ali; Ahmad Al-Fadli; Nabeel Alateeqi; Anjum Memon; Fuad Hasan
Journal:  Inflamm Bowel Dis       Date:  2011-10-10       Impact factor: 5.325

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

3.  The epidemiology of inflammatory bowel disease in Canada: a population-based study.

Authors:  Charles N Bernstein; Andre Wajda; Lawrence W Svenson; Adrian MacKenzie; Mieke Koehoorn; Maureen Jackson; Richard Fedorak; David Israel; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

4.  Clinical epidemiology of inflammatory bowel disease in Lebanon.

Authors:  Heitham Abdul-Baki; Ihab ElHajj; Lara M N El-Zahabi; Cecilio Azar; Elie Aoun; Hala Zantout; Walid Nasreddine; Bassem Ayyach; Fadi H Mourad; Assaad Soweid; Kassem A Barada; Ala I Sharara
Journal:  Inflamm Bowel Dis       Date:  2007-04       Impact factor: 5.325

5.  Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK.

Authors:  David G Walker; Horace R T Williams; Stephen P Kane; Joel E Mawdsley; Jayantha Arnold; Ian McNeil; Huw J W Thomas; Julian P Teare; Ailsa L Hart; Maxton C L Pitcher; Julian R F Walters; Sara E Marshall; Timothy R Orchard
Journal:  Am J Gastroenterol       Date:  2011-05-17       Impact factor: 10.864

6.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

7.  Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

Authors:  E V Loftus; M D Silverstein; W J Sandborn; W J Tremaine; W S Harmsen; A R Zinsmeister
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

8.  Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.

Authors:  S Ardizzone; S Bollani; P Bettica; M Bevilacqua; P Molteni; G Bianchi Porro
Journal:  J Intern Med       Date:  2000-01       Impact factor: 8.989

9.  Association of CTLA-4 gene microsatellite polymorphism with ulcerative colitis in Chinese patients.

Authors:  Yi Jiang; Bing Xia; Li Jiang; Min Lv; Qiusha Guo; Min Chen; Jin Li; Harry Hua-Xiang Xia; Benjamin Chun-Yu Wong
Journal:  Inflamm Bowel Dis       Date:  2006-05       Impact factor: 5.325

10.  Influence of vitamin D levels on bone mineral density and osteoporosis.

Authors:  Mir Sadat-Ali; Abdulmohsen H Al Elq; Haifa A Al-Turki; Fathma A Al-Mulhim; Amein K Al-Ali
Journal:  Ann Saudi Med       Date:  2011 Nov-Dec       Impact factor: 1.526

View more
  15 in total

1.  Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study.

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar
Journal:  Clin Rheumatol       Date:  2017-09-15       Impact factor: 2.980

Review 2.  Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis.

Authors:  Mahmoud Mosli; Sameer Alawadhi; Fuad Hasan; Antoine Abou Rached; Faisal Sanai; Silvio Danese
Journal:  Inflamm Intest Dis       Date:  2021-09-07

3.  A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel disease.

Authors:  Mahmoud H Mosli; Othman Al-Harbi; Brian G Feagan; Majid A Almadi
Journal:  Saudi J Gastroenterol       Date:  2015 Jul-Aug       Impact factor: 2.485

4.  Clinical characteristics, natural history, and outcomes of Crohn's-related intra-abdominal collections.

Authors:  Othman Alharbi; Majid A Almadi; Nahla Azzam; Abdulrahman M Aljebreen; Turki AlAmeel; Stefan Schreiber; Mahmoud H Mosli
Journal:  Saudi J Gastroenterol       Date:  2021 Mar-Apr       Impact factor: 2.485

5.  Epidemiological and clinical aspects of ulcerative colitis in west of Iran: a cross sectional study.

Authors:  Koroush Ghanadi; Javad Valizadeh; Afshin Hasanvand
Journal:  Springerplus       Date:  2016-09-15

6.  Inflammatory bowel disease: Clinical screening and transition of care.

Authors:  Badr Al-Bawardy
Journal:  Saudi J Gastroenterol       Date:  2017 Jul-Aug       Impact factor: 2.485

7.  Screening irritable bowel syndrome patients for symptoms predictive of crohn's disease using the red flag score.

Authors:  Mahmoud Mosli; Mutaz Bamarhul; Abdulrahman Alharbi; Sohaib Shafei; Ahmad Alharbi; Khalid Bamahfouth; Hani Jawa; Emad Aljahdali; Salim Bazaraa; Yousif Qari
Journal:  Saudi J Gastroenterol       Date:  2017 Jul-Aug       Impact factor: 2.485

8.  Rheumatic manifestations of inflammatory bowel diseases: A study from the Middle East.

Authors:  Mohammed Hammoudeh; Eman Elsayed; Saad Al-Kaabi; Manik Sharma; Mohamed Elbadri; Prem Chandra; Niveen Abu Nahia; Samer Hammoudeh
Journal:  J Int Med Res       Date:  2018-07-02       Impact factor: 1.671

9.  Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia.

Authors:  Yazed AlRuthia; Othman Alharbi; Abdulrahman M Aljebreen; Nahla A Azzam; Majid A Almadi; Ohud H Bahari; Khalid A Almalki; Abdulaziz T Atham; Ahmed S Alanazi; Maria Saeed; Baraa HajkhderMullaissa; Mohammad Alsenaidy; Bander Balkhi
Journal:  Cost Eff Resour Alloc       Date:  2019-12-04

10.  Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients.

Authors:  Heba Adam; Maryam Alqassas; Omar I Saadah; Mahmoud Mosli
Journal:  J Epidemiol Glob Health       Date:  2020-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.